Biographies

Mr. Carsten Browall has served as Independent Chairman of the Board of Directors of Vitrolife AB since April 29, 2013. He has been Independent Member of the Company's Board since April 19, 2012. He holds Master of Science degree in Business and Economics from Goteborgs Universitet. He also serves as Board Member in Unident AB, Bellman&Symfon AB and SciBase AB as well as Chairman of the Board in GHP Specialty Care AB and Osstell AB. He has experience in the medical device and healthcare sectors from senior positions in fast-growing companies such as Molnlycke, Nobel Biocare, Unfors RaySafe and Capio.

Mr. Thomas Axelsson has served as Chief Executive Officer (CEO) of Vitrolife AB since November 17, 2011. He was, among other things, CEO of Stille and Artema. Currently, he is Member of the Board of Directors at Medivir AB. He has also been Chairman of the Board of Directors at SBL Vaccin AB, Neoventa Medical AB, Dipylon Medical AB (previously CMA Microdialysis AB) and Airsonett AB, among others. He was also Business Unit Director at Baxter. He holds a Master of Science degree.

Mr. Mikael Engblom has served as Chief Financial Officer at Vitrolife AB since October 1, 2011. He has been employed by the Company since 2007. He was previously Controller at the Company, as well as Research and Development Controller at Volvo Cars. He is Board Member of AH Automation AB. He holds a Master of Business Administration degree from Handelshogskolan at Goteborgs Universitet.

Mr. Rickard Ericsson has been Vice President Market Region EMEA & Americas at Vitrolife AB since 2015. He holds M.Sc. in Industrial Engineering and Management. He previously was Business Development Director Europe at SCA Incontinence Care, Sales and Marketing Director UK & Ireland at SCA Incontinence Care, Management Consultant at Adera and Business Development Manager / Key Account Manager at Telia.

Ms. Maria Forss has been appointed Vice President Business Development & Global Communications at Vitrolife AB, effective as of October 1, 2012. She joined the Company from PULS, where she was responsible for Business Development. She previously worked as Chief Executive Officer of DuoCort Pharma, and at AstraZeneca in different positions within Marketing and Product Management. She was also Board Member of Oncorena AB. She is Board Member of LIDDS AB. She holds a Master of Science degree in Business Administration from Handelshogskolan at Goteborgs Universitet and Concordia University, Montreal.

Mr. Anders Ardstal serves as Business Unit Director Media at Vitrolife AB. He has been employed at the Company since 2012. He is also Chairman of the Board of Pmevenire AB. He previously was Vice President of Sales at LumenRadio, Management Consultant at McKinsey & Co, and held a number of operational positions at Thule. He holds Master of Science degree in Industrial Engineering and Management from Linkopings Tekniska Hogskola, a part of Linkopings Universitet.

Mr. Steffen Nielsen serves as Business Unit Director Time-lapse at Vitrolife AB. He has been employed since 2014. He holds M.Sc. in Industrial Engineering and Management. He was previously COO at FertiliTech A/S, Global Supply Chain Director at Danfoss Industrial Refrigeration and held various management positions within Danfoss.

Mr. Fredrik Mattsson has served as Member of the Board of Directors at Vitrolife AB since 2007. He is also Investment Director at Bure Equity AB, Chairman of the Board of XVIVO Perfusion AB, BioLamina AB and Celemi, as well as Board Member of Life Genomics AB. Previously, he was Chief Executive Officer of Arnew Learning. He also held various managing positions within Gambro. He holds a Master of Science degree in Industrial Engineering.

Mr. Jon Sigurdsson has been Director of Vitrolife AB since May 5, 2015. He holds B.Sc. in Industrial Engineering and Master’s degree in Business Administration (MBA). He is also Ossur President and Chief Executive Officer, as well as Chairman of the Icelandic American Chamber of Commerce. His previous assignments include Commercial Counselor for the Icelandic Trade Council in New York, Chief Financial Officer at Alafoss, Head of the International Division of Eimskip and an Engineer for Bang and Olufsen Denmark.

Dr. Barbro Friden has served as Independent Member of the Board of Directors at Vitrolife AB since April 26, 2010. She holds Doctorate in Philosophy degree and is Doctor of Medicine, specializing in Reproductive Medicine/IVF. She also acts as CEO at Sheikh Khalifa Medical City Ajman, United Arab Emirates. She previously was CEO of Sahlgrenska University Hospital, Division Manager for Children’s Hospital of Karolinska University Hospital (Karolinska Universitetssjukhuset). She is also former Director of Fertility Center in Gotheburg and Stockholm, and Medical Editor of Lakartidningen.

Mr. Tord B. Lendau has served as Independent Member of the Board of Directors at Vitrolife AB since 2008. He was previously Head of Sandvik MedTech, as well as Chief Executive Officer of Artimplant AB, Noster Systems AB, Medtronic/Synectics, Dantec SA and Synectics Medical AB. He acts as Chairman of the Board of Scibase AB, Actea Consulting AB, Hubbster, Promimic AB and Encare AB.

Ms. Pia Marions has served as Independent Member of the Board of Directors of Vitrolife AB since April 29, 2013. She holds a Master of Science degree in Business and Economics. She also serves as Chief Financial Officer of Skandia from April 2017. Previously, she was CFO of Folksam, CFO at Carnegie Group and held senior positions at RBS (Royal Bank of Scotland), Skandia Liv, Lansforsakringar Liv, Swedish Financial Supervisory Authority (Finansinspektionen) and has worked as a Certified Public Accountant.

Related Topics:

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV. Learn more about Thomson Reuters products: